<DOC>
	<DOCNO>NCT00263783</DOCNO>
	<brief_summary>To determine safety profile single multiple dos MEDI522 patient refractory solid tumor .</brief_summary>
	<brief_title>Phase I Trial Weekly MEDI-522 Patients With Refractory Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Male post menopausal female patient histologically confirm advanced refractory solid tumor reasonable therapy exists . Patient require measurable disease . Age &gt; 18 year Patients must Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 ( see APPENDIX 1 detail ) . Patients prior surgery , radiation , chemotherapy eligible provide least 4 week elapse prior study initiation . Patients must recover treatmentrelated toxicity , surgical wound must heal . Patients prior immunotherapy approve agent eligible . Patients must hemoglobin &gt; 10.0 g/dL , ANC &gt; 1,000/mm3 , WBC &gt; 3,000/mm3,000/mm3 , platelet ³100,000/mm3 , bilirubin £2.0 mg/dL , AST/ALT great 5 time upper limit normal ( ULN ) , serum creatinine &lt; 1.5 mg/dL ( calculated creatinine clearance ³60 mL/min ) . Patients must prothrombin time ( PT ) partial thromboplatin time ( PTT ) less upper limit normal international normalize ratio ( INR ) less 1.1 . Patients must thyroxine ( T4 ) thyroidstimulating hormone ( TSH ) within normal limit . Patients must inform understand investigational nature trial give write informed consent prior receipt study medication begin study procedure . Patient known brain metastasis primary brain tumor , symptomatic pleural effusion ascites require paracentesis . Patient respiratory insufficiency require oxygen treatment , lymphangitic involvement lung . Patient evidence hematemesis , melena , hematochezia , hematuria ( 2 great urine dipstick ) . Patient history significant adverse event relate previously administer humanize monoclonal antibody . Patient known HIV hepatitis virus infection . Patient prior myocardial infarction angina , uncontrolled hypertension ( systolic BP &gt; 140 mm Hg ) . Patient either prior stroke transient ischemic attack . Patient active infection require systemic antiinfective therapy physical psychological illness would preclude drug administration patient compliance . Patient donate blood receive investigational agent last 4 week . Patient history active illness behavior , include substance dependence abuse , opinion investigator , might pose additional risk administer study drug patient . General medical psychological condition would permit patient complete study sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>